Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Duke Scientists Identify New Way To Block Blood Vessels That Feed Cancer Growth

21.05.2004


Scientists from Duke University Medical Center have identified the "master switch" that cancer cells use to dispatch protective messages to nearby blood vessels, fortifying the vessels against deadly onslaughts of radiation.



The messages enable blood vessels to survive and ultimately nourish any remaining cancer cells that escape toxic radiation therapy.

Radiation biologists from the Duke Comprehensive Cancer Center identified the master switch as a protein called "Hypoxia Inducible Factor" (HIF-1) that turns on production of these protective messages.


They suppressed HIF-1 with experimental drugs given together with radiation therapy in animals with cancer. In doing so, they successfully inhibited blood vessel growth in tumors and, thereby, the growth of tumors themselves.

The Duke scientists hope to test this potential new therapy plus radiation in humans within the very near future. Results of their current findings are reported in the May, 2004, issue of Cancer Cell.

"HIF-1 is the switch inside cancer cells that gets turned on by radiation therapy," said Mark Dewhirst, Ph.D., DVM, professor of radiation oncology at Duke and principal investigator of the study. "Once it is activated, HIF-1 then triggers the production of well-known growth factors such as VEGF and bFGF, as well as more than forty different protein signals that regulate tumor metabolism, metastasis and angiogenesis." Angiogenesis is the process by which cancer cells grow new blood vessels to nourish and sustain themselves.

"By blocking the master switch, we effectively blocked many of the proteins which promote angiogenesis," said Dewhirst.

The Duke discovery follows dozens of recent developments in the field of anti-angiogenesis, in which scientists have attempted to block specific proteins that give rise to or protect tumor-feeding blood vessels.

The most noteworthy success has been Avastin, the first drug to be approved by the FDA to suppress angiogenesis in patients with spreading colorectal cancer. Avastin inhibits the protein VEGF and has been shown to extend patients’ lives when taken together with chemotherapy.

Dewhirst and first author Benjamin Moeller said their technique of suppressing HIF-1 expression could, theoretically, be a more potent inhibitor of blood vessel survival than the current approach of just suppressing a single protein, such as VEGF.

"We’re employing a treatment strategy where we accomplish two hits -- killing the cancer cells with radiation and blocking their blood vessel survival with an anti-HIF drug," said Moeller, a graduate student in the Duke M.D./Ph.D. program. "By pinpointing and blocking the source of all the signals, we have successfully halted the cancerous blood vessel growth in animals without harming normal blood vessels."

Approximately half of all cancer patients in the U.S. are treated with radiation therapy. However, the success of therapy depends largely on how sensitive a tumor’s blood vessels are to radiation. If blood vessels in the tumor survive after radiation, they can provide nutrients to the surviving cancer cells to begin rebuilding the tumor.

Thus, knowing how HIF-1 works inside cancer cells is critical to manipulating its behavior and making its blood vessels more responsive to radiation, said Moeller.

It is already known that radiation boosts oxygen levels inside cancer cells. In the new study, Moeller demonstrated that the infusion of oxygen releases pent-up RNA, the genetic blueprint molecule, for HIF-1 protein which is bound up in tiny particles called stress granules. The oxygen disintegrates these stress granules and allows HIF-1 to be produced and to engage in production of growth factors.

Secondarily, the infusion of oxygen produces "reactive oxygen species" -- also known as oxygen free radicals -- inside cancer cells. Reactive oxygen species were also shown to boost HIF-1 production, the study showed.

"Tumors so desperately seek to protect themselves against radiation that they have two completely different mechanisms for boosting HIF-1 regulated gene production to protect their blood vessels," said Dewhirst. The team’s unexpected findings shift the accepted paradigm of how HIF-1 works inside cancer cells and provides major insight into how HIF-1 regulates angiogenesis after radiation therapy, he said.

"We’ve known that oxygen levels and blood vessel growth inside tumors are two major influences on how a tumor responds to radiation and chemotherapy," said Dewhirst. "Now we’ve shown for the first time that HIF-1 is a major target we could block in combination with radiation therapy or any other therapies that causes oxygen levels to rise after treatment."

Becky Levine | dukemed news
Further information:
http://dukemednews.org/news/article.php?id=7618

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Solar Collectors from Ultra-High Performance Concrete Combine Energy Efficiency and Aesthetics

16.01.2017 | Trade Fair News

3D scans for the automotive industry

16.01.2017 | Automotive Engineering

Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs

16.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>